Hemab Therapeutics Holdings, Inc. (COAG)
39.40
-0.48
(-1.20%)
USD |
NASDAQ |
Sep 11, 16:00
39.47
+0.07
(+0.18%)
After-Hours: 20:00
Hemab Therapeutics Holdings Price : 39.40 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 40.26 | 42.48 | 38.98 | 39.40 | 408085.0 |
| Sep 10, 2026 | 44.32 | 44.52 | 39.50 | 39.88 | 433565.0 |
| Sep 09, 2026 | 44.77 | 46.20 | 43.05 | 44.50 | 429284.0 |
| Sep 08, 2026 | 44.03 | 45.49 | 43.10 | 44.57 | 360079.0 |
| Sep 04, 2026 | 43.40 | 45.49 | 43.29 | 44.41 | 302046.0 |
| Sep 03, 2026 | 44.62 | 45.28 | 43.02 | 44.37 | 257209.0 |
| Sep 02, 2026 | 44.51 | 46.83 | 42.71 | 44.70 | 325208.0 |
| Sep 01, 2026 | 45.81 | 47.00 | 43.34 | 44.02 | 318514.0 |
| Aug 31, 2026 | 44.66 | 46.43 | 43.08 | 45.73 | 591648.0 |
| Aug 28, 2026 | 48.84 | 49.37 | 44.64 | 44.84 | 260079.0 |
| Aug 27, 2026 | 49.15 | 51.11 | 48.61 | 49.49 | 354965.0 |
| Aug 26, 2026 | 49.77 | 52.00 | 47.97 | 49.19 | 334193.0 |
| Aug 25, 2026 | 46.67 | 50.36 | 46.58 | 49.65 | 527160.0 |
| Aug 24, 2026 | 49.10 | 50.15 | 46.46 | 46.67 | 336958.0 |
| Aug 21, 2026 | 48.85 | 53.00 | 46.99 | 49.16 | 391756.0 |
| Aug 20, 2026 | 50.76 | 51.69 | 46.57 | 48.20 | 426536.0 |
| Aug 19, 2026 | 53.42 | 54.05 | 50.85 | 51.66 | 279909.0 |
| Aug 18, 2026 | 53.00 | 55.36 | 52.30 | 52.44 | 183053.0 |
| Aug 17, 2026 | 54.78 | 55.18 | 51.77 | 53.59 | 208930.0 |
| Aug 14, 2026 | 53.76 | 55.42 | 50.59 | 54.94 | 101168.0 |
| Aug 13, 2026 | 54.74 | 55.18 | 52.00 | 53.95 | 171433.0 |
| Aug 12, 2026 | 52.12 | 54.66 | 50.85 | 53.48 | 278466.0 |
| Aug 11, 2026 | 49.87 | 52.27 | 49.62 | 51.74 | 251794.0 |
| Aug 10, 2026 | 49.66 | 51.80 | 48.76 | 49.87 | 299112.0 |
| Aug 07, 2026 | 52.51 | 53.33 | 48.62 | 49.66 | 415713.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Apogee Therapeutics, Inc. | 135.07 |
| Arrowhead Pharmaceuticals, Inc. | 82.85 |
| Oncolytics Biotech, Inc. | 0.7455 |
| Sangamo Therapeutics, Inc. | 0.1485 |
| Sarepta Therapeutics, Inc. | 20.45 |
Price Related Metrics
| Price to Book Value | 4.051 |
| Earnings Yield | -4.04% |
| Market Cap | 1.840B |